Contact this trialFirst, we need to learn more about you.
Chemotherapy
High-Dose Consolidation Chemotherapy for Medulloblastoma
Recruiting3 awardsPhase 4
Hackensack, New Jersey
This trial is testing whether giving a higher dose of Consolidation (a cancer treatment) to high-risk patients with medulloblastoma will improve event-free survival (EFS) and overall survival (OS) without adding significant short-term or long-term side effects.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.